Leucovorin Calcium Market Outlook:
Leucovorin Calcium Market size was valued at USD 34.38 million in 2025 and is set to exceed USD 152.98 million by 2035, expanding at over 16.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of leucovorin calcium is evaluated at USD 39.36 million.
The growth of this market can be attributed to the growing presence of cancer patients globally. Leucovorin calcium is widely used to treat cancer patients in the chemotherapy process it is used as an effective drug in the treatment. In 2020, around 20 million cancer cases were recorded all over the world.
Rising blood cells disorder such as anemia, thrombocytopenia, and neutropenia that is caused by high doses of an antagonist such as methotrexate, trimethoprim, and pyrimethamine are significant factor anticipated to drive the industry growth. In addition, growing cases of megaloblastic anemia caused by folic acid deficiency are expected to drive the market growth of the leucovorin calcium market in the forecast period. Leucovorin calcium is used to treat megaloblastic anemia in cases when oral therapy is not feasible. About 1 in 7.5 thousand people develop megaloblastic anemia in the United States every year.
